Cargando…

Commentary: Heart Failure with Preserved Ejection Fraction Induces Beiging in Adipose Tissue

Detalles Bibliográficos
Autor principal:	Chirumbolo, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779995/ https://www.ncbi.nlm.nih.gov/pubmed/27014086 http://dx.doi.org/10.3389/fphys.2016.00085

Ejemplares similares

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
por: D’Amario, Domenico, et al.
Publicado: (2019)

Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Lakhani, Ishan, et al.
Publicado: (2019)

Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
por: Dhore-patil, Aneesh, et al.
Publicado: (2022)

Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
por: Budde, Heidi, et al.
Publicado: (2022)

Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology
por: Gevaert, Andreas B., et al.
Publicado: (2019)

Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?
por: Cornuault, Lauriane, et al.
Publicado: (2022)

Editorial: Heart failure with preserved ejection fraction: Basic, translational, and clinical research
por: Brette, Fabien, et al.
Publicado: (2022)

Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction
por: Dabiri, Yaghoub, et al.
Publicado: (2018)

Remote Hind-Limb Ischemia Mechanism of Preserved Ejection Fraction During Heart Failure
por: Homme, Rubens P., et al.
Publicado: (2021)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Pabel, Steffen, et al.
Publicado: (2021)

Mimicking Metabolic Disturbance in Establishing Animal Models of Heart Failure With Preserved Ejection Fraction
por: Li, Hui, et al.
Publicado: (2022)

Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales
por: Oh, Albin, et al.
Publicado: (2019)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Importance of epicardial adipose tissue as a predictor of heart failure with preserved ejection fraction
por: Ateş, Kenan, et al.
Publicado: (2022)

Quantification of Biventricular Strains in Heart Failure With Preserved Ejection Fraction Patient Using Hyperelastic Warping Method
por: Zou, Hua, et al.
Publicado: (2018)

Potential Role of the Retrotrapezoid Nucleus in Mediating Cardio-Respiratory Dysfunction in Heart Failure With Preserved Ejection Fraction
por: Toledo, Camilo, et al.
Publicado: (2022)

Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction
por: Li, Chenyu, et al.
Publicado: (2022)

Stress Echocardiography-Derived E/e’ Predicts Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Chen, Zheng-Wei, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
por: Kirkman, Danielle L., et al.
Publicado: (2020)

Contractile Reserve in Heart Failure with Preserved Ejection Fraction
por: Di Lisi, Daniela, et al.
Publicado: (2022)

PVAT and Its Relation to Brown, Beige, and White Adipose Tissue in Development and Function
por: Hildebrand, Staffan, et al.
Publicado: (2018)

A Multi-Domain Simulation Study of a Pulsatile-Flow Pump Device for Heart Failure With Preserved Ejection Fraction
por: Ozturk, Caglar, et al.
Publicado: (2022)

Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2017)

Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives
por: van Woerden, Gijs, et al.
Publicado: (2022)

The Value of Neutrophil-to-Lymphocyte Ratio and Epicardial Adipose Tissue Thickness in Heart Failure With Preserved Ejection Fraction
por: Colluoglu, Tugce, et al.
Publicado: (2023)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Management of Oxidative Stress: Crosstalk Between Brown/Beige Adipose Tissues and Skeletal Muscles
por: Pan, Ruping, et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Visceral adiposity, muscle composition, and exercise tolerance in heart failure with preserved ejection fraction
por: Ying, Wendy, et al.
Publicado: (2021)

Adiposity and clinical outcomes in East Asian patients with heart failure and preserved ejection fraction
por: Seki, Yuko, et al.
Publicado: (2022)

Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
por: van de Wouw, Jens, et al.
Publicado: (2019)

Epicardial Adipose Tissue and Development of Atrial Fibrillation (AFIB) and Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Zain, Sarmad, et al.
Publicado: (2023)

Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

Neuregulin 4 Is a Novel Marker of Beige Adipocyte Precursor Cells in Human Adipose Tissue
por: Comas, Ferran, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hgsl27sgtpqj8f0a8di67jbiu0